MitoGenetics LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:MitoGenetics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013525
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MitoGenetics LLC (MitoGenetics) is a biomedical research and development company which produces proprietary compounds and intellectual property for the treatment of human, animal and plant diseases caused due to mitochondrial dysfunction. The company offers technology to regulate cellular mitochondria. Its patent portfolio encompasses a number of provisional or pending patents for various disorders such as morphine precursor and related patents for morphine insufficiency syndrome. MitoGenetics focuses its research activities on therapeutic interventions that affect mitochondrial performance and restore its normal function in disorders. The company licenses its technology to other companies and academic institutions to advance development of its compounds. It operates laboratory in Sioux Falls, South Dakota, the US. MitoGenetics is headquartered in Farmingdale, New York, the US.

MitoGenetics LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MitoGenetics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MitoGenetics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MitoGenetics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MitoGenetics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
MitoGenetics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
MitoGenetics LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
MitoGenetics Raises Additional USD2.2 Million in Financing Round 10
MitoGenetics Raises USD0.3 Million in Financing Round 11
MitoGenetics Raises US$1.44 Million In Extended Venture Financing Round 12
MitoGenetics Raises US$0.04 Million In Venture Financing 13
MitoGenetics LLC – Key Competitors 14
MitoGenetics LLC – Key Employees 15
MitoGenetics LLC – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
MitoGenetics LLC, Pharmaceuticals & Healthcare, Key Facts 2
MitoGenetics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MitoGenetics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MitoGenetics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MitoGenetics LLC, Deals By Therapy Area, 2011 to YTD 2017 8
MitoGenetics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
MitoGenetics Raises Additional USD2.2 Million in Financing Round 10
MitoGenetics Raises USD0.3 Million in Financing Round 11
MitoGenetics Raises US$1.44 Million In Extended Venture Financing Round 12
MitoGenetics Raises US$0.04 Million In Venture Financing 13
MitoGenetics LLC, Key Competitors 14
MitoGenetics LLC, Key Employees 15

★海外企業調査レポート[MitoGenetics LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Apartment Investment and Management Co:企業の戦略・SWOT・財務情報
    Apartment Investment and Management Co - Strategy, SWOT and Corporate Finance Report Summary Apartment Investment and Management Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Bionik Laboratories Corp (BNKL):企業の製品パイプライン分析2018
    Summary Bionik Laboratories Corp (Bionik) is a medical device company that designs and develops transformational technologies, prosthetics and assisted robotic products and solutions. The company provides rehabilitation technology that senses patient movements and limitations. It provides lower body …
  • Tanzania Electric Supply Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Tanzania Electric Supply Co Ltd (TANESCO), formerly Tanganyika Electric Supply Co Ltd, is a government-owned integrated power company. The company’s operations are regulated by the Ministry of Energy and Minerals. It generates, transmits, distributes and supplies electricity. TANESCO generat …
  • Diebold Nixdorf, Incorporated:戦略・SWOT・企業財務分析
    Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • AVEO Pharmaceuticals Inc (AVEO):製薬・医療:M&Aディール及び事業提携情報
    Summary AVEO Pharmaceuticals Inc (AVEO) is a biopharmaceutical company which focuses on the discovery, development and commercialization of drugs for the treatment of various types of cancers. Its proprietary platform delivers insights into cancer and related diseases. AVEO develops its lead candida …
  • University of Leeds:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Leeds (University of Leeds) is an educational university that offers academic programs. The university offers undergraduate, post graduate, research degrees, online and distance learning educational programs. It offers education programs in the areas of arts, biological science …
  • Illumina Inc (ILMN):医療機器:M&Aディール及び事業提携情報
    Summary Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microar …
  • EL Sewedy Electric Co (SWDY):電力:M&Aディール及び事業提携情報
    Summary EL Sewedy Electric Co (ELSE) is an integrated energy solutions company. It manufactures and supplies power cables, wires, insulators, transformers, terminators, joint accessories, meters and systems, telecom cables and accessories, fiber optic cables and accessories, wind blades, wind towers …
  • Global Franchise Architects Co.,Ltd.:企業の戦略・SWOT・財務分析
    Global Franchise Architects Co.,Ltd. - Strategy, SWOT and Corporate Finance Report Summary Global Franchise Architects Co.,Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Verizon Communications Inc (VZ):企業の財務・戦略的SWOT分析
    Verizon Communications Inc (VZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Opiant Pharmaceuticals Inc (OPNT):医療機器:M&Aディール及び事業提携情報
    Summary Opiant Pharmaceuticals Inc (Opiant), formerly, Lightlake Therapeutics Inc is a specialty pharmaceutical company that develops pharmacological treatments for substance use, addiction and eating disorders. It focuses on developing treatments to reverse opioid overdoses, for overweight and obes …
  • Singulex Inc-医療機器分野:企業M&A・提携分析
    Summary Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and p …
  • Dino Polska S.A (DNP):企業の財務・戦略的SWOT分析
    Dino Polska S.A (DNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Glenmark Pharmaceuticals Limited:企業のM&A・事業提携・投資動向
    Glenmark Pharmaceuticals Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Glenmark Pharmaceuticals Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Oceania Cruises, Inc.
    Oceania Cruises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oceania Cruises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • NanoViricides Inc (NNVC):企業の財務・戦略的SWOT分析
    Summary NanoViricides Inc (NanoViricides) is a nano-biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening viral infections. The company offers nanoviricide drug candidates against epidemic influenzas and bir …
  • Indraprastha Gas Ltd (IGL):企業の財務・戦略的SWOT分析
    Summary Indraprastha Gas Ltd (IGL) is an oil and gas company that supplies natural gas. The company offers piped natural gas, liquefied natural gas, R-LNG and compressed natural gas for industrial and commercial usage. IGL compressed natural gas is used for transportation. The company's piped natura …
  • Transport for London:企業の戦略的SWOT分析
    Transport for London - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Korean Air Lines Co Ltd:企業の戦略・SWOT・財務情報
    Korean Air Lines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Korean Air Lines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Mott MacDonald Group Ltd:企業の戦略的SWOT分析
    Mott MacDonald Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆